Prelude Therapeutics Incorporat

Q4 2021 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filers
79
Total reported value, excl. options
$438M
Manager Report Date Value ($000) Shares Option Type